| Authors: |
Tzaridis T; Cancer Genome and Epigenetics Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA., Liu J; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Chien FL; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Malhotra A; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Zhu D; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Gershon I; Department of Pediatrics, Emory University, Atlanta, Georgia, USA., Zhang H; Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA., Velazquez Vega JE; Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Schniederjan M; Department of Pathology, Children's Healthcare of Atlanta, Atlanta, Georgia, USA., Sposito T; Division of Regenerative Medicine, Department of Medicine, Moores Cancer Center and Sanford Stem Cell Institute, UC San Diego, La Jolla, California, USA., Adams PD; Cancer Genome and Epigenetics Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA., Allen JE; Chimerix (a Jazz Pharmaceuticals Company), Durham, North Carolina, USA., Prabhu VV; Chimerix (a Jazz Pharmaceuticals Company), Durham, North Carolina, USA., Wechsler-Reya RJ; Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York, USA., MacDonald TJ; Cancer Genome and Epigenetics Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia, USA. |
